FTC Taking Legal Action Against Major Prescription Drug Middlemen
Wednesday, 10 July 2024, 20:12
FTC Lawsuits Against Drug Middlemen
The FTC is pursuing legal action against major pharmacy benefit managers (PBMs) including Optum Rx, Caremark, and Express Scripts for suspected collusion in setting drug prices. This could lead to a shake-up in the pharmaceutical industry and impact consumer access to affordable medications.
Targets: UnitedHealth Group, CVS Health, Cigna
- UnitedHealth Group: Facing legal scrutiny from the FTC over pricing practices.
- CVS Health: Allegations of anti-competitive behavior in conjunction with PBMs.
- Cigna: Express Scripts' parent company under investigation for pricing strategies.
These legal actions signal a potential shift in the regulation of medication pricing and anti-competitive practices within the healthcare sector, creating uncertainty for key players in the market.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.